CTCBIO Inc. (KOSDAQ:060590)
7,190.00
-160.00 (-2.18%)
Feb 19, 2025, 9:00 AM KST
CTCBIO Revenue
CTCBIO had revenue of 35.79B KRW in the quarter ending September 30, 2024, with 14.76% growth. This brings the company's revenue in the last twelve months to 138.95B, up 0.53% year-over-year. In the year 2023, CTCBIO had annual revenue of 137.88B, down -16.54%.
Revenue (ttm)
138.95B
Revenue Growth
+0.53%
P/S Ratio
1.23
Revenue / Employee
558.03M
Employees
249
Market Cap
170.71B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 137.88B | -27.33B | -16.54% |
Dec 31, 2022 | 165.21B | 24.89B | 17.74% |
Dec 31, 2021 | 140.32B | 10.29B | 7.91% |
Dec 31, 2020 | 130.03B | -6.09B | -4.48% |
Dec 31, 2019 | 136.12B | -2.28B | -1.64% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 300.87T |
SK hynix | 57.73T |
LG Energy Solution | 25.62T |
Samsung Biologics | 4,364.39B |
Hyundai Motor Company | 170.28T |
Celltrion | 2,876.25B |
Kia Corporation | 104.63T |
NAVER | 10.39T |